1. Home
  2. BNGO vs TOI Comparison

BNGO vs TOI Comparison

Compare BNGO & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNGO
  • TOI
  • Stock Information
  • Founded
  • BNGO 2003
  • TOI 2007
  • Country
  • BNGO United States
  • TOI United States
  • Employees
  • BNGO N/A
  • TOI N/A
  • Industry
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • TOI Medical/Nursing Services
  • Sector
  • BNGO Industrials
  • TOI Health Care
  • Exchange
  • BNGO Nasdaq
  • TOI Nasdaq
  • Market Cap
  • BNGO 24.3M
  • TOI 22.6M
  • IPO Year
  • BNGO 2018
  • TOI N/A
  • Fundamental
  • Price
  • BNGO $0.19
  • TOI $0.70
  • Analyst Decision
  • BNGO Hold
  • TOI Strong Buy
  • Analyst Count
  • BNGO 3
  • TOI 1
  • Target Price
  • BNGO $1.00
  • TOI $2.50
  • AVG Volume (30 Days)
  • BNGO 16.7M
  • TOI 957.0K
  • Earning Date
  • BNGO 03-04-2025
  • TOI 11-13-2024
  • Dividend Yield
  • BNGO N/A
  • TOI N/A
  • EPS Growth
  • BNGO N/A
  • TOI N/A
  • EPS
  • BNGO N/A
  • TOI N/A
  • Revenue
  • BNGO $33,334,000.00
  • TOI $378,933,000.00
  • Revenue This Year
  • BNGO N/A
  • TOI $29.17
  • Revenue Next Year
  • BNGO $6.18
  • TOI $16.43
  • P/E Ratio
  • BNGO N/A
  • TOI N/A
  • Revenue Growth
  • BNGO N/A
  • TOI 22.29
  • 52 Week Low
  • BNGO $0.17
  • TOI $0.13
  • 52 Week High
  • BNGO $1.36
  • TOI $2.45
  • Technical
  • Relative Strength Index (RSI)
  • BNGO 39.40
  • TOI 89.45
  • Support Level
  • BNGO $0.17
  • TOI $0.25
  • Resistance Level
  • BNGO $0.26
  • TOI $0.50
  • Average True Range (ATR)
  • BNGO 0.05
  • TOI 0.09
  • MACD
  • BNGO -0.01
  • TOI 0.04
  • Stochastic Oscillator
  • BNGO 7.38
  • TOI 91.74

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.

Share on Social Networks: